List of epidemiology patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11682117 Deep interactive learning for image segmentation models	Patent 11682117 was granted and assigned to Memorial Sloan Kettering Cancer Center on June, 2023 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11682117	June 20, 2023
‌ US Patent 10963673 Identifying regions of interest from whole slide images	Patent 10963673 was granted and assigned to Memorial Sloan Kettering Cancer Center on March, 2021 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	10963673	March 30, 2021
‌ US Patent 11633502 Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use	Patent 11633502 was granted and assigned to Memorial Sloan Kettering Cancer Center on April, 2023 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11633502	April 25, 2023
‌ US Patent 11446400 Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11446400	September 20, 2022
‌ US Patent 11682186 Detection of annotated regions of interest in images	Patent 11682186 was granted and assigned to Memorial Sloan Kettering Cancer Center on June, 2023 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11682186	June 20, 2023
‌ US Patent 11603570 Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11603570	March 14, 2023
‌ US Patent 11065350 HSP90-targeted inflammation and infection imaging and therapy	Patent 11065350 was granted and assigned to Memorial Sloan Kettering Cancer Center on July, 2021 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11065350	July 20, 2021
‌ US Patent 11377637 Transgenic T cell and chimeric antigen receptor T cell compositions and related methods		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11377637	July 5, 2022
‌ US Patent 11538155 Systems and methods for multiple instance learning for classification and localization in biomedical imaging	Patent 11538155 was granted and assigned to Memorial Sloan Kettering Cancer Center on December, 2022 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11538155	December 27, 2022
‌ US Patent 11033613 Methods and compositions for treating cancer	Patent 11033613 was granted and assigned to Memorial Sloan Kettering Cancer Center on June, 2021 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11033613	June 15, 2021
‌ US Patent 11568618 Systems and methods for designing and manufacturing custom immobilization molds for use in medical procedures	Patent 11568618 was granted and assigned to Memorial Sloan Kettering Cancer Center on January, 2023 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11568618	January 31, 2023
‌ US Patent 11285209 Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors	Patent 11285209 was granted and assigned to Memorial Sloan Kettering Cancer Center on March, 2022 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11285209	March 29, 2022
‌ US Patent 11560546 Methods for neural conversion of human embryonic stem cells		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11560546	January 24, 2023
‌ US Patent 7979373 Method and system for analyzing drug adverse effects	Patent 7979373 was granted and assigned to DrugLogic on July, 2011 by the United States Patent and Trademark Office.		‌ DrugLogic	United States Patent and Trademark Office	7979373	July 12, 2011
‌ US Patent 11648268 Immune cell compositions and methods of using same	Patent 11648268 was granted and assigned to Memorial Sloan Kettering Cancer Center on May, 2023 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11648268	May 16, 2023
‌ US Patent 11501434 Deep multi-magnification networks for multi-class image segmentation		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11501434	November 15, 2022
‌ US Patent 11369322 Methods and systems for retrospective internal gating	Patent 11369322 was granted and assigned to Memorial Sloan Kettering Cancer Center on June, 2022 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11369322	June 28, 2022
‌ US Patent 11242375 Immune cell compositions and methods of use	Patent 11242375 was granted and assigned to Memorial Sloan Kettering Cancer Center on February, 2022 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11242375	February 8, 2022
‌ US Patent 9129084 Method and system for analyzing drug adverse effects	Patent 9129084 was granted and assigned to DrugLogic on September, 2015 by the United States Patent and Trademark Office.		‌ DrugLogic	United States Patent and Trademark Office	9129084	September 8, 2015
‌ US Patent 11449994 Machine learning model for analyzing pathology data from metastatic sites		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11449994	September 20, 2022
‌ US Patent 11337965 Kinase mutation-associated neurodegenerative disorders	Patent 11337965 was granted and assigned to Memorial Sloan Kettering Cancer Center on May, 2022 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11337965	May 24, 2022
‌ US Patent 11464448 Innate metabolic imaging of cellular systems		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11464448	October 11, 2022
‌ US Patent 11433040 Methods for modifying endoplasmic reticulum processing of protein	Patent 11433040 was granted and assigned to Memorial Sloan Kettering Cancer Center on September, 2022 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11433040	September 6, 2022
‌ US Patent 11441190 Compositions and methods for the diagnosis and treatment of ovarian cancers that are associated with reduced SMARCA4 gene expression or protein function		Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11441190	September 13, 2022
‌ US Patent 11458139 Use of BRAF inhibitors for treating cutaneous reactions caused by treatment with a MEK inhibitor	Patent 11458139 was granted and assigned to Memorial Sloan Kettering Cancer Center on October, 2022 by the United States Patent and Trademark Office.	Memorial Sloan Kettering Cancer Center	Memorial Sloan Kettering Cancer Center	United States Patent and Trademark Office	11458139	October 4, 2022

Results per page:

94 results

0 selected

94 results

0 selected